BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tadros HJ, Life CS, Garcia G, Pirozzi E, Jones EG, Datta S, Parvatiyar MS, Chase PB, Allen HD, Kim JJ, Pinto JR, Landstrom AP. Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes. J Mol Cell Cardiol 2020;142:118-25. [PMID: 32278834 DOI: 10.1016/j.yjmcc.2020.04.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Coscarella IL, Landim-Vieira M, Pinto JR, Chelko SP. Arrhythmogenic Cardiomyopathy: Exercise Pitfalls, Role of Connexin-43, and Moving beyond Antiarrhythmics. Int J Mol Sci 2022;23:8753. [PMID: 35955883 DOI: 10.3390/ijms23158753] [Reference Citation Analysis]
2 Ušaj M, Moretto L, Månsson A. Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy. Int J Mol Sci 2022;23:2195. [PMID: 35216312 DOI: 10.3390/ijms23042195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Migliore L, Galvagni F, Pierantozzi E, Sorrentino V, Rossi D. Allele-specific silencing by RNAi of R92Q and R173W mutations in cardiac troponin T. Exp Biol Med (Maywood). [DOI: 10.1177/15353702211072453] [Reference Citation Analysis]
4 Shafaattalab S, Li AY, Gunawan MG, Kim B, Jayousi F, Maaref Y, Song Z, Weiss JN, Solaro RJ, Qu Z, Tibbits GF. Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant I79N. Front Cell Dev Biol 2021;9:787581. [PMID: 34977031 DOI: 10.3389/fcell.2021.787581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Parker LE, Landstrom AP. The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care. Prog Pediatr Cardiol 2021;62:101413. [PMID: 34776723 DOI: 10.1016/j.ppedcard.2021.101413] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Chaulin AM. Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 2. Life (Basel) 2021;11:1175. [PMID: 34833051 DOI: 10.3390/life11111175] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Santini L, Coppini R, Cerbai E. Ion Channel Impairment and Myofilament Ca2+ Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy. Cells 2021;10:2789. [PMID: 34685769 DOI: 10.3390/cells10102789] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Hassoun R, Budde H, Mügge A, Hamdani N. Cardiomyocyte Dysfunction in Inherited Cardiomyopathies. Int J Mol Sci 2021;22:11154. [PMID: 34681814 DOI: 10.3390/ijms222011154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chaulin AM. Cardiac Troponins Metabolism: From Biochemical Mechanisms to Clinical Practice (Literature Review). Int J Mol Sci 2021;22:10928. [PMID: 34681585 DOI: 10.3390/ijms222010928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ezekian JE, Rehder C, Kishnani PS, Landstrom AP. Interpretation of Incidental Genetic Findings Localizing to Genes Associated With Cardiac Channelopathies and Cardiomyopathies. Circ Genom Precis Med 2021;14:e003200. [PMID: 34384235 DOI: 10.1161/CIRCGEN.120.003200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Shi Y, Bethea JP, Hetzel-Ebben HL, Landim-Vieira M, Mayper RJ, Williams RL, Kessler LE, Ruiz AM, Gargiulo K, Rose JSM, Platt G, Pinto JR, Washburn BK, Chase PB. Mandibular muscle troponin of the Florida carpenter ant Camponotus floridanus: extending our insights into invertebrate Ca2+ regulation. J Muscle Res Cell Motil 2021;42:399-417. [PMID: 34255253 DOI: 10.1007/s10974-021-09606-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Marques MA, Landim-Vieira M, Moraes AH, Sun B, Johnston JR, Dieseldorff Jones KM, Cino EA, Parvatiyar MS, Valera IC, Silva JL, Galkin VE, Chase PB, Kekenes-Huskey PM, de Oliveira GAP, Pinto JR. Anomalous structural dynamics of minimally frustrated residues in cardiac troponin C triggers hypertrophic cardiomyopathy. Chem Sci 2021;12:7308-23. [PMID: 34163821 DOI: 10.1039/d1sc01886h] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Mori AA, Castro LR, Bortolin RH, Bastos GM, Oliveira VF, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Pachón-Mateos JC, Correia EB, Sousa AGMR, Brión M, Carracedo A, Hirata RDC, Hirata MH. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Forensic Sci Int Genet 2021;52:102478. [PMID: 33588347 DOI: 10.1016/j.fsigen.2021.102478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cimiotti D, Budde H, Hassoun R, Jaquet K. Genetic Restrictive Cardiomyopathy: Causes and Consequences-An Integrative Approach. Int J Mol Sci 2021;22:E558. [PMID: 33429969 DOI: 10.3390/ijms22020558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Reinoso TR, Landim-Vieira M, Shi Y, Johnston JR, Chase PB, Parvatiyar MS, Landstrom AP, Pinto JR, Tadros HJ. A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C. J Muscle Res Cell Motil 2021;42:323-42. [PMID: 33179204 DOI: 10.1007/s10974-020-09592-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Sabater-Molina M, Navarro-Peñalver M, Muñoz-Esparza C, Esteban-Gil Á, Santos-Mateo JJ, Gimeno JR. Genetic Factors Involved in Cardiomyopathies and in Cancer. J Clin Med 2020;9:E1702. [PMID: 32498335 DOI: 10.3390/jcm9061702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]